A-RET 0.025% Gel (Tretinoin)
| Active Ingredient (Generic Name): | Tretinoin |
| Manufacturer: | Menarini India Pvt Ltd |
| Packaging: | 20g in Gel |
| Strength: | 0.025% |
| Delivery Time: | 6 To 15 days |
| SKU: | A-RET 0.025% Gel (Tretinoin) |
Product details
| Quantity |
12 Gel/s ,24 Gel/s ,3 Gel/s ,6 Gel/s |
|---|
Description
Customer Reviews
Related Products
Isotroin 20 mg (Isotretinoin)
Price range: $99.00 through $288.00
Select options
This product has multiple variants. The options may be chosen on the product page
Aziderm 10% Gel (Azelaic Acid)
Price range: $75.00 through $276.00
Select options
This product has multiple variants. The options may be chosen on the product page
Aziderm 20% Cream (Azelaic Acid)
Price range: $90.00 through $336.00
Select options
This product has multiple variants. The options may be chosen on the product page
Clindamycin gel
Price range: $70.00 through $320.00
Select options
This product has multiple variants. The options may be chosen on the product page
Clindamycin 300 Mg
Price range: $135.00 through $1,800.00
Select options
This product has multiple variants. The options may be chosen on the product page
Folitrax 2.5 mg (Methotrexate)
Price range: $75.00 through $280.00
Select options
This product has multiple variants. The options may be chosen on the product page
Folitrax 10 mg (Methotrexate)
Price range: $200.00 through $792.00
Select options
This product has multiple variants. The options may be chosen on the product page
Folitrax 25 mg (Methotrexate)
Price range: $134.00 through $398.00
Select options
This product has multiple variants. The options may be chosen on the product page
Melalite 15 Cream (Hydroquinone/Octinoxate/Oxybenzone)
Price range: $90.00 through $336.00
Select options
This product has multiple variants. The options may be chosen on the product page
Melalite Forte Cream (Hydroquinone)
Price range: $90.00 through $336.00
Select options
This product has multiple variants. The options may be chosen on the product page
Reviews
Clear filtersThere are no reviews yet.